MODERNA COVID-19 VACCINE- cx-024414 injection, suspension 
Moderna US, Inc.

----------

Moderna COVID-19 Vaccine

PACKAGE/LABEL PRINCIPAL DISPLAY PANEL

Moderna COVID-19 Vaccine Suspension for Intramuscular Injection for use under Emergency Use Authorization Multiple-dose vial (10 doses of 0.5 mL)

PACKAGE/LABEL PRINCIPAL DISPLAY PANEL

Moderna COVID-19 Vaccine Suspension for Intramuscular Injection for use under Emergency Use Authorization Carton Label

Moderna COVID-19 Vaccine

Suspension for Intramuscular Injection

for use under Emergency Use Authorization

10 multiple-dose vials (each vial contains 10 doses (0.5 mL each).

STORE FROZEN/between -25° to -15°C (-13° to 5°F) until ready for use

MODERNA COVID-19 VACCINE 
cx-024414 injection, suspension
Product Information
Product TypeVACCINEItem Code (Source)NDC:80777-273
Route of AdministrationINTRAMUSCULAR
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
CX-024414 (UNII: EPK39PL4R4) (CX-024414 - UNII:EPK39PL4R4) CX-0244140.2 mg  in 1 mL
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:80777-273-9910 in 1 CARTON
1NDC:80777-273-105 mL in 1 VIAL; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
Unapproved drug other10/16/2020
Labeler - Moderna US, Inc. (117626450)

Revised: 10/2020
Document Id: e0651c7a-2fe2-459d-a766-0d59e919f058
Set id: e0651c7a-2fe2-459d-a766-0d59e919f058
Version: 1
Effective Time: 20201016
 
Moderna US, Inc.